Back to News
Market Impact: 0.2
CRISPR Therapeutics Announces Chief Financial Officer Transition
Source: globenewswire.com
Management & GovernanceCompany Fundamentals
CRISPR Therapeutics announced that CFO Raju Prasad, Ph.D., will step down to pursue external opportunities. The provided article text ends before giving further details, including timing or any successor announcement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
CRSP-0.20
More News
- BlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billion
- Gartner analyst behind tech rout: AI returns are not yet large enough to justify neocloud build-out
- Walmart’s Flipkart is quietly building a food delivery challenger in India
- Credit stress is threatening to unwind the AI bull. All eyes are on Oracle to hold the line
- LightStream stops accepting loan applications. Try these 6 lenders instead
- Ciena EVP DiPerna sells $308,865 in CIEN stock